{
    "clinical_study": {
        "@rank": "33317", 
        "acronym": "R2C2-II", 
        "arm_group": {
            "arm_group_label": "Abdominal obesity", 
            "arm_group_type": "Other", 
            "description": "Single arm, follow up cohort in patient with abdominal obesity. No comparator: description of interventions :\nComposition of body mass by Dual x-ray absorptiometry Pulse wave velocity Electrocardiogram Urine sample Blood sample (and biological collection) Assessment of sleep apnea syndrome Glucose tolerance test Echocardiography Echotracking cardiac and abdominal magnetic resonance imaging Ambulatory blood pressure monitoring"
        }, 
        "brief_summary": {
            "textblock": "R2C2 study has shown that abdominal obesity is associated with a cardiac and vascular\n      remodelling in healthy volunteers. This remodelling is correlated with renin-angiotensin\n      aldosterone system (RAAS) activation and/or systemic fibrosis. R2C2 II study is designed to\n      confirm the hypothesis that RAAS is associated with an early remodelling and implicated in\n      the transition to cardiac failure in abdominal obesity."
        }, 
        "brief_title": "Role of the Renin Angiotensin Aldosterone System in the Mechanisms of Transition to Heart Failure in Abdominal Obesity", 
        "completion_date": {
            "#text": "November 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Obesity, Abdominal", 
        "condition_browse": {
            "mesh_term": [
                "Heart Failure", 
                "Obesity", 
                "Obesity, Abdominal"
            ]
        }, 
        "detailed_description": {
            "textblock": "Follow up of abdominal obesity patients from the R2C2 cohort  study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Being a former member of R2C2 study, abdominal obese group.\n\n          -  Having signed the informed consent (refusing to participate to the genetic study is\n             not an exclusion criteria).\n\n          -  being affiliated to health insurance scheme.\n\n        Inclusion Criteria of R2C2 study:\n\n          -  Men and women aged between 40 and 65 year's old\n\n          -  Caucasian\n\n          -  Born or living in France for at least 10 years\n\n          -  Presenting an abdominal obesity defined by a waist circumference >94 cm in men and \u2265\n             80 cm in women, associated or not with untreated hypertension or hypertension treated\n             for less than one year\n\n          -  Having signed the informed consent\n\n        Exclusion Criteria:\n\n          -  Subjects unable to understand the information letter\n\n          -  Subjects under supervision or guardianship\n\n          -  pregnant or lactating woman\n\n          -  A contraindication to perform MRI is not an exclusion criteria."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "72 Years", 
            "minimum_age": "43 Years"
        }, 
        "enrollment": {
            "#text": "116", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 26, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01716819", 
            "org_study_id": "2012-A00574-39"
        }, 
        "intervention": [
            {
                "arm_group_label": "Abdominal obesity", 
                "description": "dosages on one spot and 24h collection", 
                "intervention_name": "Urine sample", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Abdominal obesity", 
                "description": "dosages", 
                "intervention_name": "Blood sample", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Abdominal obesity", 
                "intervention_name": "Assessment of sleep apnea syndrome", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Abdominal obesity", 
                "intervention_name": "Electrocardiogram", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Abdominal obesity", 
                "intervention_name": "Glucose tolerance test", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Abdominal obesity", 
                "intervention_name": "Echocardiography", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Abdominal obesity", 
                "intervention_name": "cardiac and abdominal magnetic resonance imaging", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Abdominal obesity", 
                "intervention_name": "Ambulatory blood pressure monitoring", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Abdominal obesity", 
                "intervention_name": "Echotracking", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Abdominal obesity", 
                "intervention_name": "Pulse wave velocity", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Abdominal obesity", 
                "intervention_name": "Composition of body mass by Dual x-ray absorptiometry", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "Heart failure, abdominal obesity, RAAS", 
        "lastchanged_date": "February 24, 2014", 
        "location": {
            "contact": {
                "email": "p.rossignol@chu-nancy.fr", 
                "last_name": "Patrick ROSSIGNOL", 
                "phone": "+33 3 83 15 73 20"
            }, 
            "facility": {
                "address": {
                    "city": "Vandoeuvre L\u00e8s Nancy", 
                    "country": "France", 
                    "state": "Meurthe et Moselle", 
                    "zip": "54500"
                }, 
                "name": "CIC-P - INSERM - Institut Lorrain du C\u0153ur et des vaisseaux"
            }, 
            "investigator": [
                {
                    "last_name": "Faiez ZANNAD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Pierre-Yves MARIE", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Jean-Marc BOIVIN", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Daniela DOBRE", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Jos\u00e9 MEDINA", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Damien MANDRY", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Wassila DJABALLAH", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "C\u00e9dric PASQUIER", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Jacques FELBLINGER", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Anne PIZARD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Bruno GUERCI", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Philippe BOHME", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Role of the Renin Angiotensin Aldosterone System and Remodeling of the Matrix Cardiac Extra Cellular in the Mechanisms of Transition to Heart Failure in Abdominal Obesity: Prospective Longitudinal Study R2C2 II", 
        "overall_contact": {
            "email": "p.rossignol@chu-nancy.fr", 
            "last_name": "Patrick ROSSIGNOL", 
            "phone": "+33383157320"
        }, 
        "overall_contact_backup": {
            "email": "f.zannad@chu-nancy.fr", 
            "last_name": "Faiez ZANNAD", 
            "phone": "+33383157320"
        }, 
        "overall_official": {
            "affiliation": "CIC-P - INSERM - Institut Lorrain du C\u0153ur et des vaisseaux Louis Mathieu", 
            "last_name": "Patrick ROSSIGNOL", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Initial values of cardiac extracellular matrix remodelling biomarkers and the evolution of biomarkers at 3-7 years", 
            "measure": "cardiac extracellular matrix remodelling", 
            "safety_issue": "No", 
            "time_frame": "3-7 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01716819"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Evolution of cardiac and vascular phenotype in 3-7 years.", 
            "measure": "Cardiac and arterial phenotype", 
            "safety_issue": "No", 
            "time_frame": "3-7 years"
        }, 
        "source": "Central Hospital, Nancy, France", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Central Hospital, Nancy, France", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}